DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Herceptin (Trastuzumab) - Pyrexia - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Pyrexia (42)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Herceptin (Trastuzumab) where reactions include pyrexia. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 42   Next >>

Possible Herceptin side effects in female

Reported by a physician from Germany on 2012-08-17

Patient: female, weighing 91.0 kg (200.2 pounds)

Reactions: General Physical Health Deterioration, Pyrexia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Placebo
    Dosage: loading dose as per protocol
    Indication: Breast Cancer
    Start date: 2012-06-01
    End date: 2012-06-01

Carboplatin
    Dosage: last dose prior to 2nd episode: 13/jul/2012
    Indication: Breast Cancer
    Start date: 2012-06-01

Placebo
    Dosage: estimated start date of maintenance dose. last dose prior to 1st episode: 22/jun/2012, last dose pri
    Start date: 2012-06-22

Herceptin
    Dosage: loading dose as per protocol, last dose prior to sae : 13/jul/2012
    Indication: Breast Cancer
    Start date: 2012-06-01
    End date: 2012-06-01

Herceptin
    Dosage: estimated start date of maintenance dose. last dose prior to 1st episode: 22/jun/2012, last dose pri
    Start date: 2012-06-22

Other drugs received by patient: Omeprazole; Vitamin B Complex CAP



Possible Herceptin side effects in 42 year old female

Reported by a physician from France on 2012-08-15

Patient: 42 year old female, weighing 58.0 kg (127.6 pounds)

Reactions: Agranulocytosis, Pyrexia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Herceptin
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-06-28
    End date: 2012-06-28

Carboplatin
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-06-28
    End date: 2012-06-28

Docetaxel
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-06-28
    End date: 2012-06-28

Other drugs received by patient: Piperacillin and Tazobactam



Possible Herceptin side effects in female

Reported by a physician from Germany on 2012-08-10

Patient: female, weighing 61.0 kg (134.2 pounds)

Reactions: Hypocalcaemia, Pyrexia, Hypokalaemia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Doxorubicin HCL
    Dosage: drug used: non pegylated liposomal doxorubicin, last dose prior sae 30/may/2012
    Indication: Breast Cancer
    Start date: 2012-03-12

Herceptin
    Dosage: last dose prior to sae 21/may/2012
    Indication: Breast Cancer
    Start date: 2012-03-12

Paclitaxel
    Dosage: last dose prior to sae 30/may/2012
    Indication: Breast Cancer
    Start date: 2012-03-12

Herceptin
    Dosage: last dose prior to sae 21/may/2012, 366 mg

Lapatinib
    Dosage: last dose prior to sae :31/may/2012
    Administration route: Oral
    Indication: Breast Cancer
    Start date: 2012-03-12



Possible Herceptin side effects in female

Reported by a physician from Germany on 2012-08-10

Patient: female, weighing 91.0 kg (200.2 pounds)

Reactions: General Physical Health Deterioration, Pyrexia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Herceptin
    Dosage: estimated start date of maintenance dose. last dose prior to 1st episode: 22/jun/2012, last dose pri
    Start date: 2012-06-22

Herceptin
    Dosage: loading dose as per protocol
    Indication: Breast Cancer
    Start date: 2012-06-01
    End date: 2012-06-01

Placebo
    Dosage: loading dose as per protocol
    Indication: Breast Cancer
    Start date: 2012-06-01
    End date: 2012-06-01

Placebo
    Dosage: estimated start date of maintenance dose. last dose prior to 1st episode: 22/jun/2012, last dose pri
    Start date: 2012-06-22

Carboplatin
    Dosage: last dose prior to 2nd episode: 13/jul/2012
    Indication: Breast Cancer
    Start date: 2012-06-01

Other drugs received by patient: Omeprazole; Vitamin B Complex CAP



Possible Herceptin side effects in female

Reported by a physician from United Kingdom on 2012-08-09

Patient: female, weighing 104.7 kg (230.3 pounds)

Reactions: Oral Pain, Pyrexia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Herceptin
    Indication: Breast Cancer
    Start date: 2012-06-22

Placebo
    Dosage: date of last dose prior to sae: 22/jun/2012, 52 weeks
    Indication: Breast Cancer
    Start date: 2012-06-22

Docetaxel
    Dosage: date of last dose prior to sae: 22/jun/2012
    Indication: Breast Cancer
    Start date: 2012-06-22

Other drugs received by patient: Levothyroxine Sodium; Lansoprazole



Possible Herceptin side effects in 60 year old female

Reported by a physician from Sweden on 2012-08-03

Patient: 60 year old female

Reactions: Swelling Face, Pain in Extremity, Skin Ulcer, Pain of Skin, Pyrexia, Skin Reaction

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Herceptin



Possible Herceptin side effects in female

Reported by a physician from Germany on 2012-07-26

Patient: female, weighing 77.0 kg (169.4 pounds)

Reactions: Pneumonia Viral, Interstitial Lung Disease, Respiratory Failure, Pyrexia, Multi-Organ Disorder, Pulmonary Mycosis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Paclitaxel
    Indication: Breast Cancer
    Start date: 2012-05-07
    End date: 2012-07-09

Doxorubicin HCL
    Indication: Breast Cancer
    Start date: 2012-05-07
    End date: 2012-07-09

Herceptin
    Indication: Breast Cancer
    Start date: 2012-05-07
    End date: 2012-07-09

Lapatinib
    Dosage: 750 milligram;
    Administration route: Oral
    Indication: Breast Cancer
    Start date: 2012-05-07

Other drugs received by patient: Thyranojod; Acetaminophen



Possible Herceptin side effects in female

Reported by a physician from Germany on 2012-07-19

Patient: female

Reactions: Weight Decreased, Pulmonary Embolism, Pyrexia, Hyperhidrosis, Cardiac Disorder, Intestinal Perforation, Dyspepsia, Proteinuria, Epistaxis, Gingival Bleeding, Anaemia, Cardiomyopathy, Neutropenia, Hypersensitivity, Bone Pain, Pain, Chills, Skin Reaction, Abdominal Pain Upper, Polyneuropathy, Myalgia, Fatigue, Oedema, Dizziness, Myocardial Infarction, Nail Toxicity, Thrombocytopenia, Decreased Appetite, Vomiting, Dyspnoea, Nausea, Palmar-Plantar Erythrodysaesthesia Syndrome, Rash, Cerebrovascular Accident, Dysgeusia, Mucosal Inflammation, Anxiety, Diarrhoea, Impaired Healing, Arthralgia, Hypertension, Asthenia, Leukopenia

Drug(s) suspected as cause:
Avastin
    Indication: Breast Cancer

Herceptin
    Indication: Breast Cancer

Xeloda
    Indication: Breast Cancer



Possible Herceptin side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-03

Patient: female, weighing 69.7 kg (153.3 pounds)

Reactions: Cellulitis, Pleurisy, Chills, Hypotension, Streptococcus Test Positive, Headache, Pyrexia, Rash, Device Failure, Neck Pain, Chest Pain

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Carboplatin

Herceptin
    Dosage: 6mg/kg q3w iv
    Indication: Breast Cancer
    Start date: 2012-02-22

Abraxane



Possible Herceptin side effects in female

Reported by a physician from Germany on 2012-06-22

Patient: female, weighing 61.0 kg (134.2 pounds)

Reactions: Weight Decreased, Syncope, Urosepsis, Atrioventricular Block, Pyrexia, Hypokalaemia, Leukopenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Herceptin
    Dosage: last dose prior to sae: 24/may/2012
    Indication: Gastric Cancer
    End date: 2012-05-24

Docetaxel
    Dosage: last dose prior to sae: 24/may/2012
    Indication: Gastric Cancer
    End date: 2012-05-24

Oxaliplatin
    Dosage: last dose prior to sae: 24/may/2012
    Indication: Gastric Cancer
    End date: 2012-05-24

Fluorouracil
    Dosage: last dose prior to sae: 25/may/2012
    Indication: Gastric Cancer
    End date: 2012-05-25

Other drugs received by patient: Nebivolol; Simvastatin; Levothyroxine Sodium; Metoclopramide; Granisetron; Vitamin B-12; Novalgin; Enalapril Maleate



Possible Herceptin side effects in female

Reported by a consumer/non-health professional from United States on 2012-05-30

Patient: female

Reactions: Pain, Pyrexia, Somnolence, Cardiac Disorder, Fatigue, Unevaluable Event, Hepatic Pain, Rash, Alcohol Poisoning, Stress, Syncope, Neoplasm Malignant, Mastectomy, Mental Disorder, Neutropenia, Feeling Abnormal, Asthenia, Bite, Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Herceptin

Other drugs received by patient: Taxol; Oxycodone HCL



Possible Herceptin side effects in female

Reported by a physician from Germany on 2012-05-24

Patient: female, weighing 66.0 kg (145.2 pounds)

Reactions: Pyrexia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Paclitaxel
    Dosage: 146mg weekly
    Indication: Breast Cancer
    Start date: 2012-04-30

Lapatinib
    Dosage: 750mg per day
    Administration route: Oral
    Indication: Breast Cancer
    Start date: 2012-04-30

Carboplatin
    Dosage: 260mg weekly
    Indication: Breast Cancer
    Start date: 2012-04-30

Doxorubicin HCL
    Dosage: 37mg weekly
    Indication: Breast Cancer
    Start date: 2012-04-30

Herceptin
    Dosage: 520mg every 3 weeks
    Indication: Breast Cancer
    Start date: 2012-04-30

Other drugs received by patient: Pantoprazole; Loperamide



Possible Herceptin side effects in female

Reported by a physician from Germany on 2012-05-23

Patient: female, weighing 67.0 kg (147.4 pounds)

Reactions: Herpes Simplex, General Physical Health Deterioration, Pyrexia, Cystitis, Hypokalaemia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Herceptin
    Dosage: last dose prior to sae 10 may 2012.
    Indication: Breast Cancer
    Start date: 2012-01-11

Paclitaxel
    Dosage: last dose prior to sae 24 apr 2012. temporarily interrupted.
    Indication: Breast Cancer
    Start date: 2012-01-11
    End date: 2012-04-30

Lapatinib
    Dosage: permanently discontinued.
    Administration route: Oral
    Indication: Breast Cancer
    Start date: 2012-01-11
    End date: 2012-03-19

Doxorubicin Hydrochloride
    Dosage: last dose prior to sae 24 apr 2012. temporarily interrupted.
    Indication: Breast Cancer
    Start date: 2012-01-11
    End date: 2012-04-30

Carboplatin
    Dosage: auc-2, last dose prior to sae 24 apr 2012. temporarily interrupted.
    Indication: Breast Cancer
    Start date: 2012-01-11
    End date: 2012-04-30



Possible Herceptin side effects in female

Reported by a physician from Germany on 2012-05-17

Patient: female, weighing 76.0 kg (167.2 pounds)

Reactions: General Physical Health Deterioration, Pyrexia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Paclitaxel
    Start date: 2012-05-08

Lapatinib
    Dosage: daily
    Start date: 2012-02-28
    End date: 2012-05-01

Herceptin
    Dosage: last dose prior to sae: 14 feb 2012
    Indication: Breast Cancer
    Start date: 2012-01-24
    End date: 2012-02-21

Lapatinib
    Dosage: last dose prior to sae: 20 feb 2012
    Administration route: Oral
    Indication: Breast Cancer
    Start date: 2012-01-24
    End date: 2012-02-21

Lapatinib
    Dosage: daily
    Start date: 2012-05-15

Herceptin
    Dosage: last dose prior to sae: 17 apr 2012
    Start date: 2012-02-28

Paclitaxel
    Start date: 2012-02-28
    End date: 2012-05-02

Paclitaxel
    Dosage: last dose prior to sae: 24 apr 2012
    Indication: Breast Cancer
    Start date: 2012-01-24
    End date: 2012-02-21

Doxorubicin Hydrochloride
    Dosage: last dose prior to sae: 24 apr 2012
    Start date: 2012-05-08

Doxorubicin Hydrochloride
    Dosage: last dose prior to sae: 24 apr 2012
    Indication: Breast Cancer
    Start date: 2012-01-24
    End date: 2012-02-21

Doxorubicin Hydrochloride
    Dosage: last dose prior to sae: 24 apr 2012
    Start date: 2012-02-28
    End date: 2012-05-02



Possible Herceptin side effects in female

Reported by a physician from Germany on 2012-05-17

Patient: female, weighing 78.0 kg (171.6 pounds)

Reactions: Pyrexia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Doxorubicin HCL
    Dosage: 37mg weekly
    Indication: Breast Cancer
    Start date: 2012-01-24

Herceptin
    Dosage: 468mg every 3 weeks
    Indication: Breast Cancer
    Start date: 2012-01-24

Lapatinib
    Dosage: 750mg per day
    Indication: Breast Cancer
    Start date: 2012-01-24

Paclitaxel
    Dosage: 147mg weekly
    Indication: Breast Cancer
    Start date: 2012-01-24

Other drugs received by patient: Fucicort; Cefuroxime; Neupogen



Possible Herceptin side effects in female

Reported by a individual with unspecified qualification from Netherlands on 2012-05-16

Patient: female

Reactions: Malaise, Pyrexia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Herceptin
    Indication: Product Used FOR Unknown Indication

Blinded Candesartan
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-01-17

Vemurafenib
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-03-01
    End date: 2012-04-29

Other drugs received by patient: Clonidine; Omeprazole; Tamoxifen Citrate



Possible Herceptin side effects in female

Reported by a individual with unspecified qualification from United States on 2012-05-16

Patient: female

Reactions: Abdominal Pain, Vomiting, Nausea, Alanine Aminotransferase Increased, Anaemia, Pyrexia, Seroma, non-Cardiac Chest Pain, Diarrhoea, Embolism, Oedema Peripheral, Aspartate Aminotransferase Increased, Skin Infection

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Epirubicin Hydrochloride
    Dosage: over 15 mins on day 1
    Indication: Breast Cancer
    Start date: 2009-11-10
    End date: 2010-10-05

Paclitaxel
    Dosage: over 60 mins weekly
    Indication: Breast Cancer
    Start date: 2009-11-10
    End date: 2010-10-05

Herceptin
    Dosage: then 2 mg/kg over 30 mins for 11 weeks
    End date: 2010-10-05

Fluorouracil
    Dosage: on day 1
    Indication: Breast Cancer
    Start date: 2009-11-10
    End date: 2010-10-05

Herceptin
    Dosage: over 90 mins week 1,
    Indication: Breast Cancer
    Start date: 2009-11-10

Cyclophosphamide
    Dosage: over 30 mins on day 1
    Indication: Breast Cancer
    Start date: 2009-11-10
    End date: 2010-10-05



Possible Herceptin side effects in female

Reported by a physician from Germany on 2012-05-09

Patient: female, weighing 76.0 kg (167.2 pounds)

Reactions: General Physical Health Deterioration, Pyrexia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Herceptin
    Dosage: last dose prior to sae: 17 apr 2012
    Start date: 2012-02-28

Lapatinib
    Dosage: last dose prior to sae: 20 feb 2012
    Administration route: Oral
    Indication: Breast Cancer
    Start date: 2012-01-24
    End date: 2012-02-21

Doxorubicin HCL
    Dosage: last dose prior to sae: 24 apr 2012
    Indication: Breast Cancer
    Start date: 2012-01-24
    End date: 2012-02-21

Doxorubicin HCL
    Dosage: last dose prior to sae: 24 apr 2012
    Start date: 2012-02-28

Herceptin
    Dosage: last dose prior to sae: 14 feb 2012
    Indication: Breast Cancer
    Start date: 2012-01-24
    End date: 2012-02-21

Paclitaxel
    Dosage: last dose prior to sae: 24 apr 2012
    Indication: Breast Cancer
    Start date: 2012-01-24
    End date: 2012-02-21

Lapatinib
    Start date: 2012-02-28

Paclitaxel
    Start date: 2012-02-28



Possible Herceptin side effects in female

Reported by a physician from Germany on 2012-05-08

Patient: female, weighing 78.0 kg (171.6 pounds)

Reactions: Pyrexia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Doxorubicin HCL
    Dosage: 37mg weekly
    Indication: Breast Cancer
    Start date: 2012-01-24

Lapatinib
    Dosage: 750mg per day
    Indication: Breast Cancer
    Start date: 2012-01-24

Paclitaxel
    Dosage: 147mg weekly
    Indication: Breast Cancer
    Start date: 2012-01-24

Herceptin
    Dosage: 468mg every 3 weeks
    Indication: Breast Cancer
    Start date: 2012-01-24



Possible Herceptin side effects in

Reported by a physician from China on 2012-04-27

Patient:

Reactions: Chest Discomfort, Palpitations, Pyrexia, Hyperhidrosis, Sinus Tachycardia, Asthenia

Drug(s) suspected as cause:
Herceptin



Possible Herceptin side effects in female

Reported by a consumer/non-health professional from India on 2012-04-25

Patient: female

Reactions: Pyrexia, Amnesia

Drug(s) suspected as cause:
Herceptin



Possible Herceptin side effects in female

Reported by a physician from Argentina on 2012-04-24

Patient: female, weighing 84.0 kg (184.8 pounds)

Reactions: Acute Febrile Neutrophilic Dermatosis, Pyrexia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Herceptin
    Indication: Breast Cancer
    Start date: 2011-02-01
    End date: 2012-01-23

Herceptin

Other drugs received by patient: Paclitaxel; Enalapril Maleate



Possible Herceptin side effects in female

Reported by a physician from Germany on 2012-04-23

Patient: female, weighing 53.0 kg (116.6 pounds)

Reactions: Cachexia, Weight Decreased, Syncope, Nausea, Pancytopenia, Bacterial Infection, Pyrexia, Hypokalaemia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Herceptin
    Dosage: last dose prior to sae 02 feb 2012
    Indication: Breast Cancer
    Start date: 2011-10-06

Lapatinib
    Dosage: last dose prior to sae 31 oct 2011
    Administration route: Oral
    Indication: Breast Cancer
    Start date: 2011-10-06

Doxorubicin HCL
    Dosage: last dose prior to sae 09 feb 2012
    Indication: Breast Cancer
    Start date: 2011-10-06

Carboplatin
    Dosage: last dose prior to sae 09 feb 2012
    Indication: Breast Cancer
    Start date: 2011-10-06

Paclitaxel
    Dosage: last dose prior to sae: 09 feb 2012
    Indication: Breast Cancer
    Start date: 2011-10-06



Possible Herceptin side effects in

Reported by a physician from China on 2012-04-19

Patient:

Reactions: Chest Discomfort, Palpitations, Pyrexia, Hyperhidrosis, Asthenia, Sinus Tachycardia

Drug(s) suspected as cause:
Herceptin



Possible Herceptin side effects in male

Reported by a individual with unspecified qualification from Japan on 2012-04-13

Patient: male, weighing 65.0 kg (143.0 pounds)

Reactions: White Blood Cell Count Decreased, Stomatitis, Renal Disorder, Pain, Febrile Neutropenia, Palmar-Plantar Erythrodysaesthesia Syndrome, Pyrexia, Constipation, Haemoglobin Decreased, Malaise, Platelet Count Decreased, Hiccups, Neutrophil Count Decreased, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cisplatin
    Dosage: 60mg-120mg
    Indication: Gastric Cancer Recurrent
    Start date: 2011-04-14
    End date: 2011-09-21

Xeloda
    Dosage: 2 weeks administration followed by 1 week rest
    Administration route: Oral
    Start date: 2011-08-03

Xeloda
    Dosage: 2 weeks administration followed by 1 week rest
    Administration route: Oral
    Indication: Gastric Cancer Recurrent
    Start date: 2011-04-14
    End date: 2011-07-06

Herceptin
    Start date: 2011-05-11
    End date: 2011-06-22

Herceptin
    Start date: 2011-08-03

Herceptin
    Indication: Gastric Cancer Recurrent
    Start date: 2011-04-14
    End date: 2011-04-14

Other drugs received by patient: Loperamide HCL; Emend; Decadron; Granisetron; Allopurinol; Voltaren; Gosha-Jinki-GAN; Emend; Hydrocortisone Sodium Succinate; Emend; Dexamethasone Sodium Phosphate



Possible Herceptin side effects in female

Reported by a individual with unspecified qualification from United States on 2012-04-04

Patient: female

Reactions: Agitation, Anxiety, Confusional State, Insomnia, Pyrexia, Toxicity To Various Agents, Delusion

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Herceptin
    Indication: Breast Cancer
    Start date: 2004-11-09

Ixabepilone
    Indication: Breast Cancer

Carboplatin
    Dosage: 2 auc
    Indication: Breast Cancer

Dexamethasone
    Indication: Product Used FOR Unknown Indication

Herceptin

Herceptin

Diphenhydramine Hydrochloride
    Indication: Product Used FOR Unknown Indication



Possible Herceptin side effects in female

Reported by a physician from United Kingdom on 2012-03-26

Patient: female

Reactions: Chest Pain, Pyrexia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Herceptin
    Start date: 2012-01-06

Herceptin
    Indication: Breast Cancer Metastatic
    Start date: 2011-11-02

Paclitaxel
    Start date: 2012-01-06

Paclitaxel
    Indication: Breast Cancer Metastatic
    Start date: 2011-11-02

Other drugs received by patient: Docusate; Omeprazole; Temazepam; Mirtazapine



Possible Herceptin side effects in female

Reported by a consumer/non-health professional from Germany on 2012-03-21

Patient: female

Reactions: Renal Disorder, Chills, Pyrexia, Cystitis, Sinusitis, Nephritis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Herceptin

Herceptin
    Indication: Breast Cancer Metastatic
    Start date: 2010-01-01

Other drugs received by patient: Chemotherapy NOS; Taxol



Possible Herceptin side effects in

Reported by a physician from United States on 2012-03-16

Patient:

Reactions: Dyspnoea, Embolism, Pyrexia, Cystitis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Paclitaxel
    Indication: Breast Cancer
    Start date: 2011-10-24

Herceptin
    Dosage: over 30 min for 15 wks

Lapatinib
    Dosage: last dose: 19 dec2011
    Administration route: Oral
    Indication: Breast Cancer
    Start date: 2011-10-24

Herceptin
    Dosage: over 90 min wk 1
    Indication: Breast Cancer
    Start date: 2011-10-24



Possible Herceptin side effects in 85 year old female

Reported by a physician from France on 2012-03-01

Patient: 85 year old female

Reactions: Dyspnoea, Pyrexia, Erythema, Oxygen Saturation Decreased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Herceptin

Other drugs received by patient: Zofran



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014